Rochester, NY 8/6/2009 5:33:29 PM
Pre-Market - Rigel Pharmaceuticals, Inc., RIGL - Rigel Pharmaceuticals loss $29.9M in Second Quarter
Rigel Pharmaceuticals
Rigel Pharmaceuticals loss $29.9 million covering its second quarter this last June, down from a loss of $34 million in the second quarter a year earlier.
http://StockEinstein.com offers free daily stock alerts on companies ready to run. Scroll to the bottom of this page to signup for free stock alerts and visit our site.
Rigel reported no revenue in the second quarter of either 2009 or 2008. At quarter’s end Rigel had cash, cash equivalents and near money worth $79.9 million – enough, it thinks, to keep operating through the second quarter of 2010.
StockEinstein.com has a dedicated team uncovering stocks ready to break and run. We apply time tested criteria and when one of these stocks meets or exceeds our benchmarks, our subscribers are immediately notified directly to their in-box.
This is a free service available only to our subscribers. Scroll to the bottom of this page to signup for free stock alerts and visit our site.
During 2009 our alerts have resulted in an average price gain of 80%+.
Disclaimer: Full disclaimer at http://StockEinstein.com/disclaimer.php
IMPORTANT: Never invest in any stock featured in any press release, email or website unless you can afford the loss of your entire investment. Stocks and particularly penny stocks have the possibility for dramatic gains, and also losses. Neither StockEinstein, nor any of its affiliates are registered investment advisors or broker dealers.
